Annette Snejbjerg Bartels
Biomedical Laboratory Scientist
Molecular and Cellular Pharmacology
Jagtvej 160, København Ø
1 - 1 out of 1Page size: 10
- 2015
- Published
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial
Erber, R., Gluz, O., Brünner, N., Kreipe, H. H., Pelz, E., Kates, R., Bartels, Annette Snejbjerg, Huober, J., Mohrmann, S., Moustafa, Z., Liedtke, C., Möbus, V., Augustin, D., Thomssen, C., Jänicke, F., Kiechle, M., Kuhn, W., Nitz, U., Harbeck, N. & Hartmann, A., Apr 2015, In: Breast Cancer Research and Treatment. 150, 2, p. 279-288 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 6090964
Most downloads
-
864
downloads
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
849
downloads
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
687
downloads
Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Published